https://www.pharmaceutical-technology.com/data-insights/osimertinib-mesylate-astrazeneca-non-small-cell-lung-carcinoma-likelihood-of-approval/
Osimertinib mesylate is under clinical development by AstraZeneca and currently in Phase II for Non-Small Cell Lung Carcinoma.
osimertinib mesylatesmall celllung carcinomaastrazenecanon
https://www.mskcc.org/news/new-rare-type-of-small-cell-lung-cancer-identified-by-msk-research-team
A team of doctors and researchers at MSK have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never...
small cell carcinomalung canceratypicalraretype
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1349888/full
The aim of this study is to examine the predictive factors for cancer-specific survival (CSS) in patients diagnosed with Small-Cell Carcinoma of the Prostate...
frontiersprognosticnomogrampredictcancer
https://www.cancer.org/cancer/types/lung-cancer/treating-small-cell.html
Learn about the different treatments for small cell lung cancer such as chemotherapy, immunotherapy, and radiation as well as possible side effects.
lung cancer treatmentsmall cellcarcinomaamerican
https://pubmed.ncbi.nlm.nih.gov/40832222/
Probabilistic spatial modelling techniques developed on large-scale tumor-immune Atlases (~35M individually mapped cells; 50,000 high power fields) were used...
small celllung carcinomanovelpredictivespatial
https://www.pharmaceutical-technology.com/data-insights/cadonilimab-akeso-squamous-non-small-cell-lung-carcinoma-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-280693&utm_campaign=recommended-articles-pi
Cadonilimab is under clinical development by Akeso and currently in Phase II for Squamous Non-Small Cell Lung Carcinoma.
small celllung carcinomacadonilimabakesosquamous
https://pubmed.ncbi.nlm.nih.gov/28766886/
The SCLC combination screen examined a 9-point concentration response of 180 third agents, alone and in combination with etoposide/carboplatin. The predominant...
small celllung carcinomalinescreenetoposide